Weiss Multi-Strategy Advisers’s Stemline Therapeutics, Inc. STML Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-81,770	Closed	-$396K	–	642
2020 Q1	$396K	Buy	81,770 +46,770	+134%	+$303K	0.02%	357
2019 Q4	$372K	Buy	35,000 +15,000	+75%	+$149K	0.01%	551
2019 Q3	$208K	Buy	+20,000	New	+$262K	﹤0.01%	545
2013 Q4	–	Sell	-15,000	Closed	-$679K	–	1166
2013 Q3	$679K	Buy	+15,000	New	+$489K	0.01%	470

Weiss Multi-Strategy Advisers's STML Position: Q2 2020 in Review

Weiss Multi-Strategy Advisers sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 81,770 shares — an estimated $396K sold.

Weiss Multi-Strategy Advisers first reported a position in STML in Q3 2013 and held it in 4 quarters. The position peaked at $679K in Q3 2013. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Weiss Multi-Strategy Advisers reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 81,770 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $396K.
Weiss Multi-Strategy Advisers first reported a position in Stemline Therapeutics, Inc. in Q3 2013 and held it in 4 quarters.
Weiss Multi-Strategy Advisers's Stemline Therapeutics, Inc. position peaked at $679K in Q3 2013.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.